Overview
- Justice Sachin Datta said the October 17 consent order was not intended to permit fresh manufacturing of beverages using the term “ORS.”
- The court asked FSSAI to conclude its decision on JNTL Consumer Health’s representation by October 31 and indicated it may restrain manufacturers if the regulator does not act.
- FSSAI’s counsel told the court a decision on JNTL’s representation would be taken by Friday after a hearing scheduled for Tuesday at 4 pm.
- Dr Reddy’s Laboratories sought permission to dispose of existing Rebalanz VITORS stock worth over ₹1 crore, with the court signaling it will first await FSSAI’s decision.
- Paediatricians criticized the regulator’s silence as non-compliant products remained available, and the PIB fact-check unit labeled posts claiming FSSAI permitted ORSL sales as misleading.